LPCN - UP 44% YTD - Bullish Momentum Still Moving

Lipocine, Inc. operates as a pharmaceutical company, which engages in the research and development of treatment for use in men's and women's health through proprietary drug delivery technologies. It focuses on the oral testosterone replacement therapy and preterm birth prevention. The company was founded in 2011 and is headquartered in Salt Lake City, UT.

P/E Current
-3.48

P/E Ratio (with extraordinary items)
-3.79

SHORT INTEREST
54.12K 07/15/19

Average Recommendation: BUY

Average Target Price: 5.67